Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
927.11
809.73
770.24
751.59
747.45
577.21
689.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
927.11
809.73
770.24
751.59
747.45
577.21
689.31
Raw Material Cost
386.26
372.51
339.12
330.04
385.27
260.26
260.00
Purchase of Finished goods
61.25
49.29
51.35
44.34
34.91
81.34
175.67
(Increase) / Decrease In Stocks
-22.44
-8.11
-8.35
26.94
-29.20
-11.88
4.30
Employee Cost
136.43
112.05
95.58
86.17
76.15
68.09
53.69
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
201.59
157.30
141.92
146.78
161.98
72.75
72.33
Total Expenditure (Excl Depreciation)
763.08
683.04
619.62
634.27
629.11
470.56
565.99
Operating Profit (PBDIT) excl Other Income
164.03
126.69
150.62
117.32
118.34
106.65
123.32
Other Income
73.53
36.49
28.74
17.79
31.49
20.22
39.19
Operating Profit (PBDIT)
237.56
163.18
179.36
135.11
149.83
126.87
162.51
Interest
12.01
8.12
6.91
10.36
4.74
5.51
7.57
Exceptional Items
-2.49
0.00
-29.20
0.00
-73.59
0.00
-13.38
Gross Profit (PBDT)
223.06
155.06
143.25
124.75
71.50
121.36
141.56
Depreciation
33.48
29.42
26.38
18.67
17.33
17.23
12.59
Profit Before Tax
189.59
125.64
116.87
106.07
54.17
104.13
128.97
Tax
54.86
35.38
35.29
29.34
31.04
30.16
33.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
134.73
90.26
81.58
76.73
23.13
73.97
95.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
134.73
90.26
81.58
76.73
23.13
73.97
95.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.60
-5.96
-6.12
-5.88
-8.09
-5.48
2.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
129.13
84.30
75.45
70.86
15.04
68.49
97.27
Equity Capital
10.58
10.54
10.47
10.42
10.37
10.31
10.31
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,182.32
1,039.84
956.72
873.48
808.33
797.94
725.30
Earnings per share (EPS)
12.21
8.0
7.21
6.8
1.45
6.64
9.43
Diluted Earnings per share
12.0
7.95
7.11
6.72
1.43
6.49
9.43
Operating Profit Margin (Excl OI)
17.69%
15.65%
19.55%
15.61%
15.83%
18.48%
17.89%
Gross Profit Margin
24.06%
19.15%
18.6%
16.6%
9.57%
21.03%
20.54%
PAT Margin
14.53%
11.15%
10.59%
10.21%
3.09%
12.82%
13.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.50% vs 5.13% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 53.18% vs 11.73% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 29.47% vs -15.89% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 47.91% vs 17.51% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Bliss GVS Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
927.11
632.63
294.48
46.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
927.11
632.63
294.48
46.55%
Raw Material Cost
386.26
114.27
271.99
238.02%
Purchase of Finished goods
61.25
137.32
-76.07
-55.40%
(Increase) / Decrease In Stocks
-22.44
0.07
-22.51
-32,157.14%
Employee Cost
136.43
112.25
24.18
21.54%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
201.59
100.40
101.19
100.79%
Total Expenditure (Excl Depreciation)
763.08
464.31
298.77
64.35%
Operating Profit (PBDIT) excl Other Income
164.03
168.32
-4.29
-2.55%
Other Income
73.53
47.06
26.47
56.25%
Operating Profit (PBDIT)
237.56
215.38
22.18
10.30%
Interest
12.01
25.03
-13.02
-52.02%
Exceptional Items
-2.49
0.00
-2.49
Gross Profit (PBDT)
223.06
190.35
32.71
17.18%
Depreciation
33.48
31.25
2.23
7.14%
Profit Before Tax
189.59
159.10
30.49
19.16%
Tax
54.86
37.58
17.28
45.98%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
134.73
121.52
13.21
10.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
134.73
121.52
13.21
10.87%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-5.60
-6.16
0.56
9.09%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
129.13
115.36
13.77
11.94%
Equity Capital
10.58
46.05
-35.47
-77.02%
Face Value
1.00
10.00
0.00
Reserves
1,182.32
887.55
294.77
33.21%
Earnings per share (EPS)
12.21
25.05
-12.84
-51.26%
Diluted Earnings per share
12.00
26.39
-14.39
-54.53%
Operating Profit Margin (Excl OI)
17.69%
26.61%
0.00
-8.92%
Gross Profit Margin
24.06%
30.09%
0.00
-6.03%
PAT Margin
14.53%
19.21%
0.00
-4.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 927.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.50% vs 5.13% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 129.13 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 53.18% vs 11.73% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 164.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.47% vs -15.89% in Mar 2025
Annual - Interest
Interest 12.01 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.91% vs 17.51% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.69%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






